| 付秀梅,汤慧颖,王毓,等.中国海洋生物医药产业链发展研究[J].中国海洋药物,2020,39(6):67-73. |
| 中国海洋生物医药产业链发展研究 |
| Research on The Development of China’s MarineBiopharmaceutical Industry Chain |
| 投稿时间：2020-05-17 修订日期：2020-06-24 |
| DOI： |
| 中文关键词: 产业链 生物医药 海洋产业 战略环节 |
| English Keywords:industrial chain biomedicine marine industry strategic link |
| Fund Project: |
|
| 摘要点击次数: 3468 |
| 全文下载次数: 539 |
| 中文摘要: |
| 进入21世纪,海洋产业迅速崛起。海洋生物医药产业作为战略性新兴产业,在“蓝色药库”开发计划上升为国家战略的背景下,具有极大的发展潜力。研究聚焦于中国海洋生物医药产业链,剖析产业链各环节,阐述产业链各环节的内容及特点,分析中国海洋生物医药产业链现存问题,解析产业链未来发展的战略环节,并从产业链各环节提升、产业链整合两方面提出对策建议,以期促进中国海洋生物医药产业链的发展。 |
| English Summary: |
| Stepping into the 21st century, the marine industry has risen rapidly. As a strategic emerging industry, it has great potential for development under the background that the "Blue Drug Store" plan has become a national strategy. In this paper, China’s marine biopharmaceutical industry chain was taken as the object and each link of the chain was analyzed. The content, characteristics and existing problems of each link were also explained. The strategic links of the industry chain for future development were dissected, too. In order to promote the development of China’s chain, countermeasures and Suggestions were proposed from the aspects of industrial chain upgrading and industrial chain integration. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
| 关闭 |
|
|
|